DB Biotech - Rabbit clonal antibodies

About DB Biotech

Founded in 2006, DB Biotech has earned an international reputation for the development of high-quality antibodies used in research and routine clinical diagnostics. They are focused on the design and production of high-quality rabbit clonal antibodies developed by a novel and proprietary in-vitro cloning technology which has been developed and perfected by the DB Biotech scientific team over a period of 20 years. DB Biotech is ISO 9001:2015 and ISO 13485:2016 certified (issued by Lloyd's Register Quality Assurance).

Applications range from background-free western blots to special quantitative diagnostics, and potential applications of humanized antibodies for disease treatment purposes.

Antibodies against linear epitopes

DB Biotech’s in-vitro cloning technology enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes. These immunoglobulins are comparable in quality to their monoclonal analogue. The influence of the protein tertiary structure – frequently present in epitopes formed during production of monoclonal antibodies – is eliminated in the immunoglobulins corresponding to the clonal antibody, as DB Biotech produced antibodies correspond strictly to the conserved linear epitope of the antigen molecule. This results in a higher-quality, more specific antibody with significantly better affinity and avidity.

Product offering

Antibodies especially designed for:

  • WB, ELISA, IP and ICC application for basic research
  • IHC-P application for routine use in clinical pathologies
  • Flow cytometry